Caladrius BioSciences (NASDAQ:CLBS) CEO Interview
Interview with CEO DR. David Mazzo […]
Interview with CEO DR. David Mazzo […]
Interview with CEO Valeri Palmieri […]
Interview with Philippe Courtot, CEO […]
Expansion of Bertilimumab Phase 2 Clinical Trials to the U.S. and Europe […]
Interview with Omar Darwazah, Director of IR […]
Interview with President Scott Jenkins […]
Interview with CEO Amit Dror […]
Interview with CEO Chris Raanes […]
Interview with CEO Andrew Maltin […]
Interview with CEO Eric Converse […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com